Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

SB grows ahead of merger

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 265 No 7107p156
July 29, 2000 Business

SB grows ahead of merger

Smithkline Beecham Plc reported an increase in sales and profits for the first six months of 2000 on July 25 ahead of its planned merger with Glaxo Wellcome Plc.
Sales rose by 9 per cent to £4.07bn while pre-tax profits increased by 14 per cent to £1.06bn. The figures exclude restructuring and merger costs of £185m for the second quarter of the year and the disposal of the company's clinical laboratories business.
Mr J. P. Garnier (chief executive, SB) said that sales were driven by the continued growth of Seroxat (paroxetine) and Augmentin (co-amoxiclav). Avandia (rosiglitazone), which was launched in the United Kingdom for the treatment of type II diabetes this week (see p153), had made world-wide sales of £114m in the second quarter of 2000. UK pharmaceutical sales were up 17 per cent in the second quarter against 1999.
Glaxo Wellcome Plc was due to announce its half-year results on July 27, after The Journal went to press.

GSK merger slips Glaxo Wellcome and Smithkline Beecham announced on July 25 that the completion date for their merger had been put back from August 21 to September 25. Gaining regulatory clearance for the merger in the United States was taking longer than anticipated, the companies said.

Citation: The Pharmaceutical Journal URI: 20002351

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.